SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001213900-24-078213
Filing Date
2024-09-12
Accepted
2024-09-12 17:18:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3686
  Complete submission text file 0001213900-24-078213.txt   5280
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39138 | Film No.: 241295777
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O JASPER THERAPEUTICS, INC. 2200 BRIDGE PARKWAY, SUITE 102 REDWOOD CITY CA 94065
Business Address
Mahal Jeetinder Singh (Reporting) CIK: 0001882877 (see all company filings)

Type: 144